Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.70 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.15
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Mon, 14th Dec 2020 16:59

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Tracsis PLC - Leeds-based provider of software, hardware and services for rail, traffic data and transport industries - Chief Financial Officer Max Cawthra sells 75,000 shares at 638.7p, worth GBP479,025, on Monday. Still has 93,022 shares, a 0.3% stake.

----------

Checkit PLC - Cambridge, England-based workflow management - Executive Chair Keith Daley buys 413,775 shares at 50.1 pence, worth GBP207,301, on Friday last week. Now holds 14.8 million shares, a 23.8% stake.

----------

London Stock Exchange Group PLC - trading and clearing operator and index calculator - Non-Executive Director Dominic Blakemore buys 928 shares at GBP86.21, worth GBP79,999, on Monday.

----------

Aquila Services Group PLC - London-based consultancy and support services in affordable housing, education, sports and community services sectors - Directors and associates buy 360,000 shares at 20p, worth GBP72,000, on Thursday last week. Chair Derek Joseph, Non-Executive Director Richard Wollenberg and Executive Director Fiona Underwood each buy 120,000 shares.

----------

Ocean Wilsons Holdings Ltd - Bermuda-based investment company operating a maritime services company in Brazil - Non-Executive Director Caroline Foulger buys 5,000 shares at 874p, worth GBP42,700, on December 4 and 7. Now interested in 10,000 shares.

----------

Spirax-Sarco Engineering PLC - Cheltenham, England-based thermal energy management and pumping - Non-Executive Director Caroline Johnstone buys 443 shares at 11,241.89p, worth GBP49,802, on Thursday last week.

----------

Audioboom Group PLC - London-based podcasts producer - Non-Executive Chair Michael Tobin buys 10,050 shares at 199p, worth GBP20,000, on Friday. Now has 280,616 shares, a 1.8% stake.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical firm focussed on iron deficiency - Chief Executive Officer Tim Watts buys 100,000 shares at GBP0.70, worth GBP69,750, on Friday. Now has 548,700 shares.

----------

React Group PLC - South Derbyshire-based cleaning, hygiene and decontamination - Executive Chair Mark Braund buys 774,255 shares and CFO Andrea Pankhurst buys 463,458, both at 1.29p and together worth GBP15,966, on Friday. The shares are their only holdings. Braund was appointed at the start of this month and Pankhurst in May.

----------

SimplyBiz Group PLC - Zahid Bilgrami, CEO of Defaqto subsidiary, sells 55,000 shares at 180.00p, worth GBP99,000, on Friday. Still interested in 1.8 million shares. SimplyBiz bought Defaqto, a financial services technology firm with a platform that rates financial products and funds, for GBP74 million in March 2019.

----------

Churchill China PLC - Stoke-On-Trent, England-based ceramic products for hospitality and retail markets - CEO David O'Connor buys 4,850 shares at 1,340p, worth GBP64,990, while Finance Director David Taylor and Sales & Marketing Director James Roper each sell 2,000 shares at 1,272p, all on Friday. O'Connor now has 37,963 shares, while Taylor has 59,555. Roper has 1.0 million shares, a 9.1% stake.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 248,823 shares via Vulpes Life Sciences Fund at 10.50p, worth about GBP26,126, on Friday. Vulpes now has 117.5 million shares, a 14.4% stake.

----------

JPMorgan China Growth & Income PLC - seeks total return from companies listed in Hong Kong, China and Taiwan - Non-Executive Director Alexandra Mackesy buys 1,600 shares at 641.78p, worth GBP10,268, on Friday last week.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Jul 2020 11:24

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

Read more
24 Jun 2020 12:18

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Read more
12 Jun 2020 12:59

Scancell upbeat on publication of AvidiMab research

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.

Read more
28 Apr 2020 16:40

Director dealings: Scancell director lowers stake

(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.

Read more
28 Apr 2020 14:43

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Read more
24 Apr 2020 12:00

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Read more
24 Apr 2020 10:49

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

Read more
3 Feb 2020 14:20

Scancell's 'SCIB1' clears latest regulatory hurdle in US

(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.

Read more
3 Feb 2020 10:44

Scancell Gets US FDA Approval For SCIB1 Drug Application

Scancell Gets US FDA Approval For SCIB1 Drug Application

Read more
31 Jan 2020 11:12

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Read more
20 Jan 2020 12:04

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Read more
18 Dec 2019 16:29

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

Read more
16 Dec 2019 13:30

Scancell inks AvidiMab agreement with Chinese biotech company

(Sharecast News) - Scancell Holdings on Monday signed a collaboration and non-exclusive research agreement with an unnamed Chinese biotechnology firm.

Read more
16 Dec 2019 09:21

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Read more
12 Dec 2019 14:23

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.